Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors

Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors - methotrexate and vinblastine for patients with desmoid tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019337

Enrollment

Registered

2015-10-14

Start date

2015-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

desmoid

Interventions

Methotrexate, Vinblastine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: not controlled desmoid tumor

Exclusion criteria

Exclusion criteria: not tolerated to chemotherapy

Design outcomes

Primary

Measure	Time frame
Response rate with RECIST, and safety	—

Secondary

Measure	Time frame
relationship between clinical outcome and CTNNB1 mutation status	—

Countries

Japan

Contacts

Public ContactYoshihiro Nishida

Nagoya University Hospital Orthopaedic Surgery

ynishida@med.nagoya-u.ac.jp052-741-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026